Piper Sandler Sees Sees a 'compelling buying opportunity' in Tenax Therapeutics (TENX)

June 1, 2026 8:06 AM

Piper Sandler analyst Yasmeen Rahimi reiterated an Overweight rating and $20.00 price target on Tenax Therapeutics (NASDAQ: TENX).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found